Researchers develop biodegradable hydrogel to print human tissue

Researchers at the University of Texas at Arlington have developed a flexible biodegradable hydrogel capable of printing human tissues. The team published its findings March 18 in ACS Applied Materials and Interfaces.

"Soft tissue bio-printing suffers from significant challenges as the hydrogels were often brittle and un-stretchable and could not mimic the mechanical behavior of human soft tissues," said Yi Hong, UTA professor of bioengineering and leader of the project. “To overcome these challenges, we developed a simple system using a single cross-linking mechanism activated by visible light to achieve a highly elastic and robust, biodegradable and biocompatible hydrogel for cell printing.”

 

The elastic biodegradable hydrogel is used in the bio-printing of materials that mimic human soft tissues, including skin, skeletal muscles, blood vessels and heart muscles. By using live cells, the hydrogel builds new tissues on a scaffolding and could change cell printing.

"Polycaprolactone and poly (ethylene glycol) are already widely used in Food and Drug Administration - approved devices and implants, which should facilitate quick translation of the material into pre-clinical and clinical trials in the future," Hong said. "The tunability of the mechanical properties of this hydrogel to match different soft tissues is a real advantage.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup